USPTO published patent application US20260091017A1 titled 'Treatments for Inflammation' disclosing novel compounds, compositions, and kits comprising connexin hemichannel modulators, inflammasome modulators, and/or pannexin channel modulators. The inventions cover methods for systemic and topical administration for treating ocular and dermatological diseases, disorders, and conditions characterized by inflammasome-mediated inflammation. Inventors include Avik Shome, Odunayo Omolola Mugisho, and Ilva D. Rupenthal.

This is a published patent application (Kind A1) that establishes a priority date of September 26, 2025. Pharmaceutical and biotechnology companies developing inflammation treatments should review the claims to assess potential freedom-to-operate implications or licensing opportunities. No compliance deadlines or regulatory obligations are associated with this publication for third parties.